Today, we announced an update from our kidney xenotransplant program:
⢠5 patients transplanted with EGEN-2784
⢠3 remained dialysis-independent for more than 8 months
⢠1 has now surpassed 9 months
⢠2 successfully transitioned to human kidney transplants
𧬠What if a #PigKidney could keep patients off dialysis while they wait for a human organ?
A genetically modified pig kidney supported a 66-year-old patient for 271 days before he received a human kidneyāthe longest reported dialysis-free survival after a porcine #kidney transplant.
āļø @vanitasrivasta1 explores what this could mean for xenotransplantation.
https://t.co/MxZtze7ZzB
A truly remarkable HUMAN story of science + technology transforming lives --> NYT: In a First, a Pig Kidney Kept a Patient Alive Until He Got a Human One https://t.co/zaaUnWGYvT
A pig kidney transplant worked for a record nine months. This enabled the recipient to stay off dialysis for longer while waiting for a suitable human donor's kidney to become available https://t.co/D1BpwqnmNj
Experimental cases of giving gene-edited pig organs to people have shown promise.
In a world first, Tim Andrews, 66, from New Hampshire in the US, was given a pig kidney that enabled him to stay off dialysis for nine months. ⤵ļø
https://t.co/H4kC5MaFS5
Trials in the US involving genetically engineered pig kidneys are beginning to build up a record of clinical success after decades of unfulfilled promise, offering hope for the future of transplants. https://t.co/ZM5J7Zj5Ku
Our latest study, just published in @TheLancet, reports the first successful transition from porcine kidney #xenotransplantation to human kidney transplantation.
A genetically engineered pig kidney provided >9 months (271 days) of dialysis-free kidney function before successful human transplantation, supporting xenotransplantation as a potential bridge while preserving future transplant options.
Beyond the clinical milestone, the study provides new insights into late microvascular inflammation and innate immune activation that will help shape future immunosuppressive strategies and donor genetic engineering.
Link to article: https://t.co/RCZFq2w5vD
@mgh_transplant@MGHSurgery@MGBResearchNews@MGBKidneys@eGenesisBio
Two recipients of gene-edited pig kidneys have successfully received human organs, a milestone in the wider effort to advance xenografts. https://t.co/3Lw3BRO6ao
Today, we announced an update from our kidney xenotransplant program:
⢠5 patients transplanted with EGEN-2784
⢠3 remained dialysis-independent for more than 8 months
⢠1 has now surpassed 9 months
⢠2 successfully transitioned to human kidney transplants
Ep. 38 is live. @GrinsteinJ and @eGenesisBioās Mike Curtis, PhD on how eGenesis kidney transplant cases are reframing xenotransplantationānot as a permanent solution, but as a bridge to a human transplant. https://t.co/MQcQYCH5XbĀ
#BehindTheBreakthroughs#PrecisionMedicine
Ep. 38 of Behind the Breakthroughs: @GrinsteinJ and @eGenesisBioās Mike Curtis, PhD on how recent kidney transplant cases are reshaping xenotransplantationānot as a permanent solution, but as a bridge to a human transplant.
https://t.co/athXYFxNc1
#BehindTheBreakthroughs
.@eGenesisBio has been named to @FastCompanyās list of the Worldās Most Innovative Companies of 2026.
Weāre No. 1 in the Biotech category and ranked No. 34 on Fast Companyās2026 Worldās 50 Most Innovative Companies list.
Read our release: https://t.co/QpjDk8eazK
š Xenotransplantation named one of Natureās 7 Innovations to Watch in 2026.
From CRISPR-edited pig organs to first-in-human success, it shows xeno moving from concept to clinical reality. @mgh_transplant@eGenesisBio
š§¬š«@Nature šhttps://t.co/LAFbE48GDx